Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma in Situ × advexin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Liver Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1

Interventions

valrubicin 2 Gemcitabine 2 enfortumab vedotin 1 durvalumab 1 advexin 1 Surveys and Questionnaires 1 Standard of Care 1 Oncolytic Virotherapy 1 Nivolumab 1 Mitomycin 1 Interferons 1 Cystoscopy 1 Biopsy 1 ALT-801 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00410865 2011-12-07

Wild Type p53 Adenovirus for Oral Premalignancies

M.D. Anderson Cancer Center

Phase 1 Terminated

Carcinoma in Situ, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡